Waters Stock News

Waters press release (WAT): Q4 Non-GAAP EPS of $3.67 beats by $0.18.Revenue of $836.4M (+6.3% Y/Y) beats by $16M.Quarter led by double-digit instrument sales growth, with

Waters (WAT) delivered earnings and revenue surprises of 5.76% and 1.97%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Waters' (WAT) fourth-quarter 2021 results are likely to reflect solid momentum across pharmaceutical and industrial end markets.

Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Waters (WAT) releases the MS Quan application on the waters_connect informatics software platform to help scientists efficiently screen large number of samples and contaminants.

Waters (WAT) releases the MS Quan application on the waters_connect informatics software platform to help scientists efficiently screen large number of samples and contaminants.

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) will webcast its Q4 2021 financial results conference call live on Tuesday, February 1st 2022 at 8:00 a.m. eastern time. A live webcast o

Waters (NYSE:WAT) and Cue Health (NASDAQ:HLTH) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation and analyst recommendations. Earnings and Valuation This table compares Waters and Cue Healths revenue, earnings per share and [] The post Waters (NYSE:WAT) vs. Cue Health (NASDAQ:HLTH) Head to Head Analysis appeared first on ETF Daily News .

Amalgamated Bank lowered its holdings in shares of Waters Co. (NYSE:WAT) by 4.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,068 shares of the medical instruments supplier’s stock after selling 736 shares during the quarter. Amalgamated Bank’s holdings in Waters were worth […]

Cue Health (NASDAQ:HLTH) and Waters (NYSE:WAT) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Valuation and Earnings This table compares Cue Health and Waters gross revenue, earnings per share (EPS) and []

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will speak to the investment community at the J.P. Morgan Healthcare Conference

Livforsakringsbolaget Skandia Omsesidigt cut its position in shares of Waters Co. (NYSE:WAT) by 26.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 851 shares of the medical instruments suppliers stock after selling 300 shares during the period. Livforsakringsbolaget Skandia Omsesidigts holdings []

The Biomarker Technologies Market research report provides broad, subjective bits of knowledge on the potential and specialty portions or regions displaying good growth. The Biomarker Technologies Market research report comprehensively investigates the current and developing business sector patterns and openings